Inflammatory Myofibroblastic Tumor of the Lung: A Case Report.

inflammation inflammatory myofibroblastic tumor lung tumor mesenchymal tumor thoracic

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Sep 2024
Historique:
accepted: 24 09 2024
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: epublish

Résumé

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor classified as an intermediate malignancy that rarely metastasizes. The most common site for IMTs is the lung, though they can develop in various other anatomical locations. Pulmonary IMTs are more common in children and adolescents and are infrequently diagnosed in adults. This case report describes a 49-year-old woman with a history of breast cancer previously treated with subtotal mastectomy and chemotherapy who developed an IMT in the lung. This case emphasizes the rarity of the disease and the associated clinical challenges when managing such cases.

Identifiants

pubmed: 39463656
doi: 10.7759/cureus.70207
pmc: PMC11510679
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e70207

Informations de copyright

Copyright © 2024, Baltagianni et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Marianthi Baltagianni (M)

Department of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.

Vasileios Leivaditis (V)

Department of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, DEU.

Nikolaos Baltayiannis (N)

Department of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.

Gabriela Stanc (G)

Department of Pathology, Metaxa Cancer Hospital, Piraeus, GRC.

Efstathia Souka (E)

Department of Pathology, Metaxa Cancer Hospital, Piraeus, GRC.

Pella Batika (P)

Department of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, GRC.

Eleftherios Beltsios (E)

Department of Anesthesiology and Critical Care, Hannover Medical School, Hannover, DEU.
Department of Cardiothoracic Surgery, General University Hospital of Patras, Patras, GRC.

Francesk Mulita (F)

Department of Surgery, General University Hospital of Patras, Patras, GRC.

Athanasios Papatriantafyllou (A)

Department of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, DEU.

Efstratios N Koletsis (EN)

Department of Cardiothoracic Surgery, General University Hospital of Patras, Patras, GRC.

Classifications MeSH